Zimmer Biomet’s new meniscal repair device has been developed to offer a less invasive, all-suture, knotless alternative. Credit: Zimmer Biomet.

Zimmer Biomet has received the US Food and Drug Administration (FDA) 510(k) clearance for the use of its JuggerStitch device in meniscal repair procedures.

Conventional knotted meniscal repair devices come with hard plastic anchors and its surface knots can damage cartilage. These devices are associated with more risk of complications.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Zimmer Biomet’s meniscal repair device offers a less invasive, all-suture, knotless alternative for better patient treatment outcomes.

JuggerStitch implant has two soft anchors that are linked by a knotless, self-locking suture loop.

The company added that the device is meant for improved tissue preservation and control of the tissue compression at the repair site, compared to implants requiring sliding knot to lock the repair.

Zimmer Biomet meniscal repair range, which also includes CrossFix and MaxFire MarXmen devices, is part of its sports medicine portfolio.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The portfolio also comprises products for repairs of the rotator cuff, shoulder labral and biceps and AC joint, among others.

Zimmer Biomet chief medical officer Dr Andrew Freiberg said: “Zimmer Biomet is committed to delivering cutting-edge technology and solutions, like the next-generation JuggerStitch meniscal repair device, to help surgeons alleviate pain, restore peak performance and improve the quality of life for patients.

“Our comprehensive sports medicine portfolio provides a variety of options that help patients throughout the care continuum.”

Founded in 1927, the company focuses on musculoskeletal healthcare. It develops products and solutions for disorders or injuries of bones and joints, as well as supporting soft tissues.

In March, Zimmer Biomet secured FDA clearance for its ROSA ONE Spine System in robotically assisted surgeries. The spine system integrates a real-time patient tracking capability and 3D intra-operative planning software for improved placement of implants.